Heat shock proteins in antigen trafficking–Implications on antigen presentation to T cells

References

• Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989; 7: 601–624
   PubMed Web of Science ®Google Scholar
• Rammensee HG, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993; 11: 213–244
   PubMed Web of Science ®Google Scholar
• Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 1999; 17: 739–779
   PubMed Web of Science ®Google Scholar
• Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000; 404: 770–774
   PubMed Web of Science ®Google Scholar
• Yewdell JW, Anton LC, Bennink JR. Defective ribosomal products (DRiPs): A major source of antigenic peptides for MHC class I molecules?. J Immunol 1996; 157: 1823–1826
   PubMed Web of Science ®Google Scholar
• Qian SB, Reits E, Neefjes J, Deslich JM, Bennink JR, Yewdell JW. Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol 2006; 177: 227–233
   PubMed Web of Science ®Google Scholar
• Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 2005; 207: 145–157
   PubMed Web of Science ®Google Scholar
• Murata S, Minami Y, Minami M, Chiba T, Tanaka K. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep 2001; 2: 1133–1138
   PubMed Web of Science ®Google Scholar
• Murata S, Chiba T, Tanaka K. CHIP: A quality-control E3 ligase collaborating with molecular chaperones. Int J Biochem Cell Biol 2003; 35: 572–578
   PubMed Web of Science ®Google Scholar
• Kunisawa J, Shastri N. Hsp90α chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 2006; 24: 523–534
   PubMed Web of Science ®Google Scholar
• Kunisawa J, Shastri N. The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol Cell 2003; 12: 565–576
   PubMed Web of Science ®Google Scholar
• Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, Patterson C. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 1999; 19: 4535–4545
   PubMed Web of Science ®Google Scholar
• McDonough H, Patterson C. CHIP: A link between the chaperone and proteasome systems. Cell Stress Chaperones 2003; 8: 303–308
   PubMed Web of Science ®Google Scholar
• Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 2001; 3: 100–105
   PubMed Web of Science ®Google Scholar
• Workman P. Overview: Translating Hsp90 biology into Hsp90 drugs. Curr Cancer Drug Targets 2003; 3: 297–300
   PubMed Web of Science ®Google Scholar
• Lu C, Chen D, Zhang Z, Fang F, Wu Y, Luo L, Yin Z. Heat Shock Protein 90 regulates the stability of c-Jun in HEK293 Cells. Mol Cells 2007; 24: 210–214
   PubMed Web of Science ®Google Scholar
• Zhang L, Nephew KP, Gallagher PJ. Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes. J Biol Chem 2007; 282: 11795–11804
   PubMed Web of Science ®Google Scholar
• Matei D, Satpathy M, Cao L, Lai YC, Nakshatri H, Donner DB. The platelet-derived growth factor receptor α is destabilized by geldanamycins in cancer cells. J Biol Chem 2007; 282: 445–453
   PubMed Web of Science ®Google Scholar
• Yamano T, Murata S, Shimbara N, Tanaka N, Chiba T, Tanaka K, Yui K, Udono H. Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing. J Exp Med 2002; 196: 185–196
   PubMed Web of Science ®Google Scholar
• Callahan MK, Garg MM, Srivastava PK. Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation. Proc Natl Acad Sci USA 2008; 105: 1662–1667
   PubMed Web of Science ®Google Scholar
• Loo MA, Jensen TJ, Cui L, Hou Y, Chang XB, Riordan JR. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J 1998; 17: 6879–6887
   PubMed Web of Science ®Google Scholar
• Fuller W, Cuthbert AW. Post-translational disruption of the delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes delta F508 CFTR in the rabbit reticulocyte lysate. J Biol Chem 2000; 275: 37462–37468
   PubMed Web of Science ®Google Scholar
• Yamano T, Mizukami S, Murata S, Chiba T, Tanaka K, Udono H. Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing. J Biol Chem 2008; 283: 28060–28065
   PubMed Web of Science ®Google Scholar
• Imai J, Maruya M, Yashiroda H, Yahara I, Tanaka K. The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome. EMBO J 2003; 22: 3557–3567
   PubMed Web of Science ®Google Scholar
• Babbitt SE, Kiss A, Deffenbaugh AE, Chang YH, Bailly E, Erdjument-Bromage H, Tempst P, Buranda T, Sklar LA, Baumler J, et al. ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle. Cell 2005; 121: 553–565
   PubMed Web of Science ®Google Scholar
• Kriegenburg F, Seeger M, Saeki Y, Tanaka K, Lauridsen AM, Hartmann-Petersen R, Hendil KB. Mammalian 26S proteasomes remain intact during protein degradation. Cell 2008; 135: 355–365
   PubMed Web of Science ®Google Scholar
• Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007; 316: 612–616
   PubMed Web of Science ®Google Scholar
• Rajagopal D, Bal V, Mayor S, George A, Rath S. A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules. Eur J Immunol 2006; 36: 828–841
   PubMed Web of Science ®Google Scholar
• Rock KL. Exiting the outside world for cross-presentation. Immunity 2006; 25: 523–525
   PubMed Web of Science ®Google Scholar
• Steinman RM. Dendritic cells in vivo: A key target for a new vaccine science. Immunity 2008; 29: 319–324
   PubMed Web of Science ®Google Scholar
• Huang AY, Bruce AT, Pardoll DM, Levitsky HI. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 1996; 4: 349–355
   PubMed Web of Science ®Google Scholar
• Bevan MJ. Cross-priming. Nat Immunol 2006; 7: 363–365
   PubMed Web of Science ®Google Scholar
• Ackerman AL, Giodini A, Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006; 25: 607–617
   PubMed Web of Science ®Google Scholar
• Jarosch E, Taxis C, Volkwein C, Bordallo J, Finley D, Wolf DH, Sommer T. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol 2002; 4: 134–139
   PubMed Web of Science ®Google Scholar
• Tsai B, Ye Y, Rapoport TA. Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol 2002; 3: 246–255
   PubMed Web of Science ®Google Scholar
• Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, Steele-Mortimer O, Paiement J, Bergeron JJ, Desjardins M. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 2002; 110: 119–131
   PubMed Web of Science ®Google Scholar
• Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003; 425: 397–402
   PubMed Web of Science ®Google Scholar
• Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A, Princiotta MF, Thibault P, Sacks D, Desjardins M. Phagosomes are competent organelles for antigen cross-presentation. Nature 2003; 425: 402–406
   PubMed Web of Science ®Google Scholar
• Van den Berg B, Clemons WM, Jr, Collinson I, Modis Y, Hartmann E, Harrison SC. Rapoport TA. 2004. X-ray structure of a protein-conducting channel. Nature 2004; 427: 36–44
   PubMed Web of Science ®Google Scholar
• Lin ML, Zhan Y, Villadangos JA, Lew AM. The cell biology of cross-presentation and the role of dendritic cell subsets. Immunol Cell Biol 2008; 86: 353–362
   PubMed Web of Science ®Google Scholar
• Brodsky JL. The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). Biochem J 2007; 404: 353–363
   PubMed Web of Science ®Google Scholar
• Nishikawa S, Brodsky JL, Nakatsukasa K. Roles of molecular chaperones in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). J Biochem 2005; 137: 551–555
   PubMed Web of Science ®Google Scholar
• Fewell SW, Travers KJ, Weissman JS, Brodsky JL. The action of molecular chaperones in the early secretory pathway. Annu Rev Genet 2001; 35: 149–191
   PubMed Web of Science ®Google Scholar
• Huyer G, Piluek WF, Fansler Z, Kreft SG, Hochstrasser M, Brodsky JL, Michaelis S. Distinct machinery is required in Saccharomyces cerevisiae for the endoplasmic reticulum-associated degradation of a multispanning membrane protein and a soluble luminal protein. J Biol Chem 2004; 279: 38369–38378
   PubMed Web of Science ®Google Scholar
• Vashist S, Ng DT. Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J Cell Biol 2004; 165: 41–52
   PubMed Web of Science ®Google Scholar
• Nakatsukasa K, Huyer G, Michaelis S, Brodsky JL. Dissecting the ER-associated degradation of a misfolded polytopic membrane protein. Cell 2008; 132: 101–112
   PubMed Web of Science ®Google Scholar
• Imai J, Hasegawa H, Maruya M, Koyasu S, Yahara I. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells. Int Immunol 2005; 17: 45–53
   PubMed Web of Science ®Google Scholar
• Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 1993; 178: 1391–1396
   PubMed Web of Science ®Google Scholar
• Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997; 278: 117–120
   PubMed Web of Science ®Google Scholar
• Ishii T, Udono H, Yamano T, Ohta H, Uenaka A, Ono T, Hizuta A, Tanaka N, Srivastava PK, Nakayama E. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J Immunol 1999; 162: 1303–1309
   PubMed Web of Science ®Google Scholar
• Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995; 269: 1585–1588
   PubMed Web of Science ®Google Scholar
• Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20: 395–425
   PubMed Web of Science ®Google Scholar
• Binder RJ, Han DK, Srivastava PK. CD91: A receptor for heat shock protein gp96. Nat Immunol 2000; 1: 151–155
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001; 14: 303–313
   PubMed Web of Science ®Google Scholar
• FitzGerald DJ, Fryling CM, Zdanovsky A, Saelinger CB, Kounnas M, Winkles JA, Strickl D, Leppla S. Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein. J Cell Biol 1995; 129: 1533–1541
   PubMed Web of Science ®Google Scholar
• Zheng H, Li Z. Cutting edge: Cross-presentation of cell-associated antigens to MHC class I molecule is regulated by a major transcription factor for heat shock proteins. J Immunol 2004; 173: 5929–5933
   PubMed Web of Science ®Google Scholar
• Binder RJ, Srivastava PK. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol 2005; 6: 593–599
   PubMed Web of Science ®Google Scholar
• Shen L, Rock KL. Cellular protein is the source of cross-priming antigen in vivo. Proc Natl Acad Sci USA 2004; 101: 3035–3040
   PubMed Web of Science ®Google Scholar
• Manjili MH, Henderson R, Wang XY, Chen X, Li Y, Repasky E, Kazim L, Subjeck JR. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res 2002; 62: 1737–1742
   PubMed Web of Science ®Google Scholar
• Facciponte JG, Wang XY, Subjeck JR. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I. Eur J Immunol 2007; 37: 2268–2279
   PubMed Web of Science ®Google Scholar
• Udono H, Yamano T, Kawabata Y, Ueda M, Yui K. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol 2001; 13: 1233–1242
   PubMed Web of Science ®Google Scholar
• Mizukami S, Kajiwara C, Ishikawa H, Katayama I, Yui K, Udono H. Both CD4+ and CD8+ T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors. Cancer Sci 2008; 99: 1008–1015
   PubMed Web of Science ®Google Scholar
• Palliser D, Ploegh H, Boes M. Myeloid differentiation factor 88 is required for cross-priming in vivo. J Immunol 2004; 172: 3415–3421
   PubMed Web of Science ®Google Scholar
• Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 2008; 9: 558–566
   PubMed Web of Science ®Google Scholar